These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9886434)

  • 1. T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.
    Shirai M; Arichi T; Chen M; Masaki T; Nishioka M; Ikeda K; Takahashi H; Enomoto N; Saito T; Major ME; Nakazawa T; Akatsuka T; Feinstone SM; Berzofsky JA
    J Immunol; 1999 Jan; 162(1):568-76. PubMed ID: 9886434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes.
    Frasca L; Scottà C; Del Porto P; Nicosia A; Pasquazzi C; Versace I; Masci AM; Racioppi L; Piccolella E
    Hepatology; 2003 Sep; 38(3):653-63. PubMed ID: 12939592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells.
    Frasca L; Del Porto P; Tuosto L; Marinari B; Scottà C; Carbonari M; Nicosia A; Piccolella E
    J Immunol; 1999 Jul; 163(2):650-8. PubMed ID: 10395654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
    Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
    EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus.
    Zhou YH; Moriyama M; Esumi M
    Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
    Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
    Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo T helper cell response to retro-inverso peptidomimetics.
    Mézière C; Viguier M; Dumortier H; Lo-Man R; Leclerc C; Guillet JG; Briand JP; Muller S
    J Immunol; 1997 Oct; 159(7):3230-7. PubMed ID: 9317121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon.
    Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S
    Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
    J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of an antigen required for cellular interactions and for T cell activation in a MHC-restricted response.
    Langton BC; Mackewicz CE; Wan AM; Andria ML; Benjamini E
    J Immunol; 1988 Jul; 141(2):447-56. PubMed ID: 3260252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide.
    van Bergen J; Camps M; Offringa R; Melief CJ; Ossendorp F; Koning F
    Cancer Res; 2000 Nov; 60(22):6427-33. PubMed ID: 11103809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.
    Shang D; Zhai W; Allain JP
    Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment.
    Del Porto P; Puntoriero G; Scottà C; Nicosia A; Piccolella E
    Virology; 2000 Apr; 269(2):313-24. PubMed ID: 10753710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain.
    Battegay M; Bachmann MF; Burhkart C; Viville S; Benoist C; Mathis D; Hengartner H; Zinkernagel RM
    Cell Immunol; 1996 Jan; 167(1):115-21. PubMed ID: 8548834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules.
    Harris DP; Vordermeier HM; Arya A; Moreno C; Ivanyi J
    Immunology; 1995 Apr; 84(4):555-61. PubMed ID: 7790029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
    Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
    Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypervariable region 1 variant acting as TCR antagonist affects hepatitis C virus-specific CD4+ T cell repertoire by favoring CD95-mediated apoptosis.
    Scottà C; Tuosto L; Masci AM; Racioppi L; Piccolella E; Frasca L
    J Leukoc Biol; 2005 Aug; 78(2):372-82. PubMed ID: 15923217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.